Table 2. Association between plasma miR-744 levels and clinicopathological characteristics in PCa patients with pancreatectomy.

		Plasma miR-744 concentration		Univariatea
	n	High	Low	P-value
Total	39	19	20
Age				0.4254
<65	19	11 (58%)	8 (40%)
>66	20	8 (42%)	12 (60%)
Sex				0.2668
Male	13	9 (47%)	14 (70%)
Female	16	10 (53%)	6 (30%)
Histological type				0.5587
IPMN carcinoma	10	3 (16%)	7 (35%)
PDAC derived from IPMN	6	3 (16%)	3 (15%)
PDAC	23	13 (68%)	10 (50%)
pT (TNM)				0.1552
T1–2	11	3 (16%)	8 (40%)
T3–4	28	16 (84%)	12 (60%)
pN (TNM)				0.0407
N0	27	10 (53%)	17 (85%)
N1	12	9 (47%)	3 (15%)
pStage (TNM)				0.3501
0–II	12	4 (21%)	8 (40%)
III–IV	27	15 (79%)	12 (60%)
Recurrence				0.0376
Absent	20	6 (32%)	14 (70%)
Present	19	13 (68%)	6 (30%)

Abbreviations: IPMN=intraductal papillary mucinous neoplasm; PCa=pancreatic cancer; PDAC=pancreatic ductal adenocarcinoma; TNM=Tumour, Node, Metastasis. Significant values are in bold.

^aChi-square test.